Is hereditary site-specific ovarian cancer a distinct genetic condition?

Alexander Liede, Patricia N. Tonin, Chia Chia Sun, Corinne Serruya, Mary B. Daly, Steven A. Narod, William D. Foulkes

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Abstract

It is not clear if hereditary site-specific ovarian cancer exists as a genetic entity distinct from the hereditary breast-ovarian cancer syndrome. We have identified a large Ashkenazi Jewish kindred with 8 cases of ovarian carcinoma and no cases of breast cancer. Initially, linkage analysis for this kindred generated a negative LOD score to BRCA1, but subsequent mutation and haplotype analysis of key individuals demonstrated a BRCA1 185delAG mutation segregating with all but 1 of the ovarian cancer cases. This observation has important implications for genetic counselling of families with site-specific ovarian cancer. hereditary site-specific ovarian cancer is likely to be a variant of the hereditary breast-ovarian cancer syndrome, attributable to either BRCA1 or BRCA2. We consider women from these families to be at increased risk of breast cancer and counsel them accordingly.

Original languageEnglish
Pages (from-to)55-58
Number of pages4
JournalAmerican Journal of Medical Genetics
Volume75
Issue number1
DOIs
StatePublished - Jan 6 1998

Keywords

  • BRCA1 Protein/biosynthesis
  • Breast Neoplasms/genetics
  • Canada/ethnology
  • Carcinoma/genetics
  • Disease Susceptibility
  • Female
  • Gene Expression Regulation, Neoplastic
  • Genotype
  • Germ-Line Mutation
  • Humans
  • Jews/genetics
  • Middle Aged
  • Ovarian Neoplasms/genetics
  • Pedigree
  • Phenotype
  • Syndrome

Fingerprint

Dive into the research topics of 'Is hereditary site-specific ovarian cancer a distinct genetic condition?'. Together they form a unique fingerprint.

Cite this